TipRanks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Want to see PHAT full AI Analyst Report?

Phathom Pharmaceuticals (PHAT) Technical Analysis

606 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Phathom Pharmaceuticals’s (PHAT) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Phathom Pharmaceuticals is a Sell.
Phathom Pharmaceuticals’s (PHAT) 20-Day exponential moving average is 7.30, while Phathom Pharmaceuticals’s (PHAT) share price is $8.77, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) 50-Day exponential moving average is 8.04, while Phathom Pharmaceuticals’s (PHAT) share price is $8.77, making it a Sell.

Phathom Pharmaceuticals (PHAT) Pivot Points

Oct 21, 2026, 10:50 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.57
6.68
6.84
6.95
7.11
7.22
7.38
Fibonacci
6.68
6.78
6.84
6.95
7.05
7.11
7.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Phathom Pharmaceuticals (PHAT) Moving Averages

Oct 21, 2026, 10:50 AM
Period
Simple
Exponential
MA5
7.23Buy
7.18Buy
MA10
7.15Buy
7.17Buy
MA20
7.12Buy
7.30Buy
MA50
8.10Sell
8.04Sell
MA100
9.29Sell
9.10Sell
MA200
10.82Sell
10.73Sell
Phathom Pharmaceuticals’s (PHAT) 10-Day exponential moving average is 7.17, while Phathom Pharmaceuticals’s (PHAT) share price is $8.77, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) 100-Day exponential moving average is 9.10, while Phathom Pharmaceuticals’s (PHAT) share price is $8.77, making it a Sell.
Phathom Pharmaceuticals’s (PHAT) stock price is $8.77 and Phathom Pharmaceuticals’s (PHAT) 50-day simple moving average is 8.10, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $8.77 and Phathom Pharmaceuticals’s (PHAT) 100-day simple moving average is 9.29, creating a Sell signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $8.77 and Phathom Pharmaceuticals’s (PHAT) 200-day simple moving average is 10.82, creating a Sell signal.

Phathom Pharmaceuticals (PHAT) Technical Indicators

Oct 21, 2026, 10:50 AM
Name
Value
Implied Action
RSI (14)
47.34
Neutral
STOCH (9,6)
43.51
Neutral
STOCHRSI (14)
46.67
Neutral
MACD (12,26)
-0.26
Sell
ADX (14)
21.36
Neutral
Williams %R
-34.17
Buy
CCI (14)
36.80
Neutral
ATR (14)
0.43
-
Ultimate Oscillator
46.83
Neutral
ROC
0.14
Buy
Phathom Pharmaceuticals’s (PHAT) Relative Strength Index (RSI) is 47.34, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Trend Strength Indicator (ADX) is 21.36, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Commodity Channel Index (CCI) is 36.80, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Price Rate of Change (ROC) is 0.14, creating a Buy signal.

FAQ

Is PHAT a Buy, Hold, or Sell?
Based on PHAT’s technical indicators, PHAT is a Hold.
    What is PHAT’s RSI (14)?
    PHAT’s RSI (14) is 47.34, which suggests PHAT is a Neutral.
      What is PHAT’s MACD?
      PHAT’s MACD is -0.26, which suggests PHAT is a Sell.
        What is PHAT’s 5-day moving average?
        PHAT’s 5-day moving average is 7.23, which suggests PHAT is a Buy.
          What is PHAT’s 20-day moving average?
          PHAT 20-day moving average is 7.12, which suggests PHAT is a Buy.
            What is PHAT’s 50-day moving average?
            PHAT’s 50-day moving average is 8.10, which suggests PHAT is a Sell.
              What is PHAT’s 200-day moving average?
              PHAT’s 200-day moving average is 10.82, which suggests PHAT is a Sell.
                What is PHAT’s Williams % R (14)?
                PHAT’s Williams % R (14) is -34.17, which suggests PHAT is a Buy.
                  What is PHAT’s CCI (14)?
                  PHAT’s CCI (14) is 36.80, which suggests PHAT is a Neutral.